{
    "2018-03-20": [
        [
            {
                "time": "",
                "original_text": "千亿元级市场！疫苗行业进入快速发展阶段，这家公司业绩暴增",
                "features": {
                    "keywords": [
                        "疫苗",
                        "行业",
                        "快速发展",
                        "业绩暴增"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-03-20",
                "original_text": "明日最具投资机会六大牛股一览（3月20日）",
                "features": {
                    "keywords": [
                        "投资机会",
                        "牛股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "申万宏源：智飞生物买入评级",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "买入评级"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]医药行业周报：医疗部门体系调整 关注医药流通板块",
                "features": {
                    "keywords": [
                        "医药行业",
                        "医疗部门",
                        "体系调整",
                        "医药流通"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]智飞生物(300122)年报点评：17年业绩高增长 18年HPV疫苗将迎来销售大年",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "年报",
                        "HPV疫苗",
                        "销售大年"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]智飞生物(300122)年报点评：一季度业绩略超预期 三联苗呈高速增长态势",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "年报",
                        "一季度",
                        "三联苗",
                        "高速增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【平安】智飞生物*300122*行业恢复+三联苗快速放量，业绩符合预期*推荐",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "行业恢复",
                        "三联苗",
                        "快速放量"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]智飞生物(300122)年报点评：三联苗快速放量 HPV疫苗值得期待",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "年报",
                        "三联苗",
                        "HPV疫苗"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "智飞生物2017年业绩增长超12倍 一季度净利预计2.3亿元至2.7亿元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "2017年",
                        "业绩增长",
                        "一季度",
                        "净利预计"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]医药行业周报：国务院机构改革提升监管效率 医药行业长期趋势向好",
                "features": {
                    "keywords": [
                        "医药行业",
                        "国务院",
                        "机构改革",
                        "监管效率",
                        "长期趋势向好"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[买入-A评级]智飞生物(300122)年报点评：一季度业绩表现亮眼 看好公司未来业绩持续高增长及研发管线带来的价值重塑",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "年报",
                        "一季度",
                        "业绩表现",
                        "研发管线",
                        "价值重塑"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]智飞生物(300122)年报点评：业绩符合预期 期待HPV继续放量",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "年报",
                        "业绩符合预期",
                        "HPV",
                        "放量"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "年报将密集披露 35家公司年报现险资身影",
                "features": {
                    "keywords": [
                        "年报",
                        "险资"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-19",
                "original_text": "【医药-智飞生物(300122)】江琦：公司2017年报点评：业绩实现高增长，看好2018年4价HPV疫苗销售-20180319",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "2017年报",
                        "业绩高增长",
                        "4价HPV疫苗",
                        "销售"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【晨会聚焦】疫苗行业或迎投资机会",
                "features": {
                    "keywords": [
                        "疫苗行业",
                        "投资机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}